CD8+ CTL RECOGNITION OF MHC CLASS 1

MHC 1 类的 CD8 CTL 识别

基本信息

  • 批准号:
    6373153
  • 负责人:
  • 金额:
    $ 30.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1989
  • 资助国家:
    美国
  • 起止时间:
    1989-09-30 至 2005-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Adapted from the Investigator's abstract): The hallmark of the immune system is the remarkable ability to discriminate between self and foreign proteins displayed as peptides bound to self-major histocompatibility complex (MHC) molecules. T lymphocytes acquire this ability during development in the thymus in which low avidity interactions between T-cell receptors (TCRs) and self-MCH/peptide result in positive selection. High avidity interactions in the thymus result in negative selection and deletion of potentially autoreactive T-cell repertoire that is self-tolerant and self-MHC restricted. TCR affinity, MHC/peptide density and co-receptor engagement contribute to the overall avidity of the interaction between T-cells and antigen presenting cell (APC). This avidity sets up a balance between positive and negative selection and establishes the activation requirements of peripheral T-cells. The overall goal of this application is to correlate the thymic selection environment with the functional phenotype of the peripheral CD8T cell repertoire. Specificity of peripheral CD8 T-cells. To do this they will alter class I expression or CD8 interaction during thymic development and determine how it affects the ability of peripheral CD8 T-cells to distinguish APC expressing different levels of class I/peptide complexes. To address these questions, unique MHC Class I transgenic mice that express a single class I allele will be engineered. Using these mice, the diversity of the CD8 T-cell repertoire selected by a single class I allele, in the absence of other class I molecules, will be characterized. These analyses will probe mechanisms of tolerance to self-antigens and avoidance of autoimmune responses. Furthermore these studies will determine factors influencing activation requirements of self-restricted responses to tumor antigens and infectious virus as well as how individual MHC alleles contribute to alloreactive responses and transplantation tolerance.
描述(改编自研究者的摘要):这是

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JANET M CONNOLLY其他文献

JANET M CONNOLLY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JANET M CONNOLLY', 18)}}的其他基金

CD8+ CTL RECOGNITION OF MHC CLASS I
MHC I 类的 CD8 CTL 识别
  • 批准号:
    2837403
  • 财政年份:
    1989
  • 资助金额:
    $ 30.8万
  • 项目类别:
CD8-LYT-2 RECOGNITION OF THE CLASS I ALPHA 3 DOMAIN
CD8-LYT-2 对 I 类 ALPHA 3 结构域的识别
  • 批准号:
    3141829
  • 财政年份:
    1989
  • 资助金额:
    $ 30.8万
  • 项目类别:
CD8 T Cell Recognition of MHC Class I
CD8 T 细胞对 MHC I 类的识别
  • 批准号:
    7235726
  • 财政年份:
    1989
  • 资助金额:
    $ 30.8万
  • 项目类别:
CD8+ CTL RECOGNITION OF MHC CLASS 1
MHC 1 类的 CD8 CTL 识别
  • 批准号:
    6199417
  • 财政年份:
    1989
  • 资助金额:
    $ 30.8万
  • 项目类别:
CD8 T Cell Recognition of MHC Class I
CD8 T 细胞对 MHC I 类的识别
  • 批准号:
    7144585
  • 财政年份:
    1989
  • 资助金额:
    $ 30.8万
  • 项目类别:
CD8-LYT-2 RECOGNITION OF THE CLASS I ALPHA 3 DOMAIN
CD8-LYT-2 对 I 类 ALPHA 3 结构域的识别
  • 批准号:
    3141824
  • 财政年份:
    1989
  • 资助金额:
    $ 30.8万
  • 项目类别:
CD8 T Cell Recognition of MHC Class I
CD8 T 细胞对 MHC I 类的识别
  • 批准号:
    7628540
  • 财政年份:
    1989
  • 资助金额:
    $ 30.8万
  • 项目类别:
CD8+ CTL RECOGNITION OF MHC CLASS I
MHC I 类的 CD8 CTL 识别
  • 批准号:
    2063944
  • 财政年份:
    1989
  • 资助金额:
    $ 30.8万
  • 项目类别:
CD8+ CTL RECOGNITION OF MHC CLASS 1
MHC 1 类的 CD8 CTL 识别
  • 批准号:
    6532678
  • 财政年份:
    1989
  • 资助金额:
    $ 30.8万
  • 项目类别:
CD8 T Cell Recognition of MHC Class I
CD8 T 细胞对 MHC I 类的识别
  • 批准号:
    7851270
  • 财政年份:
    1989
  • 资助金额:
    $ 30.8万
  • 项目类别:

相似海外基金

Elucidating a molecular understanding of ILC2 MHC class I antigen cross priming
阐明 ILC2 MHC I 类抗原交叉引发的分子理解
  • 批准号:
    486527
  • 财政年份:
    2022
  • 资助金额:
    $ 30.8万
  • 项目类别:
    Studentship Programs
Restoring MHC class I antigen presentation to enhance anti-tumour immunity
恢复MHC I类抗原呈递,增强抗肿瘤免疫力
  • 批准号:
    nhmrc : GNT1164054
  • 财政年份:
    2020
  • 资助金额:
    $ 30.8万
  • 项目类别:
    Project Grants
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
  • 批准号:
    8996707
  • 财政年份:
    2014
  • 资助金额:
    $ 30.8万
  • 项目类别:
Ubiquitin conjugation and direct MHC class I antigen presentation
泛素结合和直接 MHC I 类抗原呈递
  • 批准号:
    8880646
  • 财政年份:
    2014
  • 资助金额:
    $ 30.8万
  • 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
  • 批准号:
    9206412
  • 财政年份:
    2014
  • 资助金额:
    $ 30.8万
  • 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
  • 批准号:
    8723605
  • 财政年份:
    2014
  • 资助金额:
    $ 30.8万
  • 项目类别:
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
  • 批准号:
    8072956
  • 财政年份:
    2010
  • 资助金额:
    $ 30.8万
  • 项目类别:
The function of the Ubiquitin-Proteasome-System (UPS) in MHC class I antigen processing in target cells and maturing human dendritic cells (hDCs).
泛素蛋白酶体系统 (UPS) 在靶细胞和成熟人树突细胞 (hDC) 中 MHC I 类抗原加工中的功能。
  • 批准号:
    105348415
  • 财政年份:
    2009
  • 资助金额:
    $ 30.8万
  • 项目类别:
    Research Grants
In vivo analysis of the imnportance of proteasome immunosubunits and of PA28 for MHC class I antigen processing, CTL response induction and tumor-virus elimination (A 7)
体内分析蛋白酶体免疫亚基和 PA28 对于 MHC I 类抗原加工、CTL 反应诱导和肿瘤病毒消除的重要性 (A 7)
  • 批准号:
    5354871
  • 财政年份:
    2002
  • 资助金额:
    $ 30.8万
  • 项目类别:
    Collaborative Research Centres
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
  • 批准号:
    7991835
  • 财政年份:
    2001
  • 资助金额:
    $ 30.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了